SnagRx Review: Is It Legit?

SnagRx is an online weight-loss program that sells compounded GLP-1 injections on a subscription. "SnagRx allows you to get prescription weight loss medications such as semaglutide & tirzepatide from the comfort of your home."

Here is how it goes. You answer a short health qualifier, then fill in a medical intake in the patient portal. A provider from OpenLoop Health, a network of US-licensed doctors, reviews your chart. If a GLP-1 fits, a partner pharmacy fills the prescription. The medication ships free and arrives in 1-2 days. Refills are requested through the portal.

The menu has two drugs, both compounded and both weekly injections: semaglutide and tirzepatide. There is no brand-name option. The medical practice behind the service is Modern Metabolic Medicine.

Compounded GLP-1s are prepared by a pharmacy to a prescription, and they are not FDA-approved. To understand the drugs themselves, read our pages on semaglutide and tirzepatide. SnagRx serves every US state except Louisiana, and in Nebraska only patients 19 and over.

Yes. SnagRx names its prescriber network, OpenLoop Health, and the four pharmacies that fill its prescriptions. It has no FDA warning letter and no open flag. That is more disclosure than we usually see from a compounded program, and the record behind it is clean.

The four pharmacies are Red Rock Compounding Pharmacy in St. George, UT, Health Warehouse in Florence, KY, Precision Medicine in Bellmore, NY, and Triad Rx in Daphne, AL. "Medications prescribed through SnagRx are dispensed by U.S.-based 503A compounding pharmacies." Those pharmacies compound a drug for one named patient on a prescription, and state boards oversee them. Outsourcing facilities, which make drugs in bulk, register with the FDA instead. None of the four appears in the FDA's outsourcing-facility register, which is normal for this pharmacy type.

The site says plainly that the drugs are compounded. It says they are "prescribed by a doctor and compounded by a real US based pharmacy." Traceability scores 9 out of 10.

SnagRx costs $99 a month all-in for compounded semaglutide on the monthly plan, and $149 a month for compounded tirzepatide. The medication, the provider and the shipping are included, with no other fee.

Longer plans cost less. Each one is billed once, up front, and renews for the same length unless you cancel. Semaglutide is $89 a month on a 3-month plan, billed as $267, and $79 a month on a 6-month plan, billed as $474. On a 12-month plan, semaglutide is $69 a month, billed as $828 once. Tirzepatide is $139 a month on a 3-month plan ($417) and $129 on a 6-month plan ($774). On a 12-month plan, tirzepatide is $119 a month, billed as $1,428 once. The home page leads with "Semaglutide for $69 / Tirzepatide for $119", and those are the 12-month rates.

The price stays the same as your dose rises. The terms, last updated July 27, 2026, set out each plan. They also note that "The final charge may vary based on the prescribed medication and the selected pharmacy".

There is nothing on top. The membership fee, the consultation fee and the shipping fee are each $0. SnagRx does not bill insurance. Three months at the monthly semaglutide rate total $297.

That puts SnagRx at rank 3 of the 20 compounded programs in its group on month-to-month prices. The median there is $168 a month. For scale, a pharmacy pays $871.12 for a Wegovy 1.7 mg pen package, effective September 23, 2026. That is an acquisition cost for the brand-name drug, not what a patient pays.

The care runs through a nursing team and a patient portal, not scheduled video visits. A provider reviews your chart within 24 hours, often in under 5 hours. No appointment is needed.

Medication ships within 2 business days of approval, and orders before 2pm central ship the same day. From there, the SnagRx nursing staff gives you ongoing 1:1 medical support. You request each refill in the portal, and the provider reviews your dose each time. "Our providers will do their best to match you with the dosage that best fits your needs and journey." Phone and email support are also available.

SnagRx does not state whether it asks for labs. Clinical care scores 8.6 out of 10, and a stated lab policy is what would lift it.

SnagRx has no FDA warning letter and no open flag on its record. One of its four pharmacies, Triad Rx, had an FDA warning letter in 2019 that the FDA has closed out.

The bigger question with any compounded program is the drug itself. Compounded GLP-1s are prepared by a pharmacy to a prescription. They are not FDA-approved: the FDA doesn't review their safety, effectiveness or quality before they're sold, and they are not the same as Wegovy or Zepbound. Formulas can differ from one pharmacy to the next, and some add ingredients such as vitamin B12. Compounding pharmacies are licensed and inspected by state boards of pharmacy; outsourcing facilities (503B) also register with the FDA and are inspected by it. The FDA can issue warning letters when either breaks rules on safety or sterility. SnagRx's intake carries a note of its own: "For those taking Tirzepatide , we recommend switching to a non-oral contraceptive method or adding a barrier method of contraception for four weeks after initiation and for four weeks after each dose escalation."

For side effects, doses and who should not take these drugs, read our semaglutide and tirzepatide pages, which quote the FDA labels. Safety scores 9.25 out of 10 on this record.

It depends on the plan. The monthly plans cancel at any time, with no minimum term. The 3-, 6- and 12-month plans are a commitment: you agree to the full term, and the $69 and $119 rates come with a 12-month lock. Cancelling a long plan stops its renewal only; no part of what you paid is refunded.

Timing matters. To stop the next charge, the refund policy asks for your request at least 72 hours before your next billing date. The terms ask for it at least 5 days before the end of your prescription period. You can cancel by email, by phone or in your patient portal.

All payments are final: the only refund is when a provider finds you are not clinically eligible. In that case, SnagRx refunds the unused part of your current term, minus the cost of services already given, such as the consultation, the provider review and any shipped medication. SnagRx also makes no promise about results.

So the trap is simple. Do not prepay $828 or $1,428 for the headline rate unless you are sure you will stay on the drug for a year. If you have side effects, talk to your provider. Terms score 8 out of 10: the monthly plans are clean, the annual lock costs the rest.

SnagRx publishes no customer testimonials on the pages we read. The site sells on price and speed instead: a $69 headline rate, a provider review in under a day and delivery in 1-2 days.

This site collects no independent reviews, so there are no patient stories here to weigh. Look at independent reviews for how support and refills go in practice. The prices and terms above tell you what you will pay and what you sign. Ask how SnagRx handles a dose change before you commit to a long plan. If you have side effects, talk to your provider.

Our score combines seven checks. Each one counts for a fixed share of the total, listed below. Commission is not an input.

• Price transparency: 10/10 (counts for 20% of the total score). Every fee is $0, every price held on re-read, and the 12-month rates are labeled.
• Cost and value: 9/10 (counts for 15% of the total score). Rank 4 of 21 on month-to-month prices, no fee load.
• Medication and pharmacy traceability: 9/10 (counts for 15% of the total score). Four pharmacies named and their type stated.
• Clinical access and oversight: 8.6/10 (counts for 15% of the total score). A named prescriber network and a stated wait time, no lab policy.
• Safety and enforcement: 9.25/10 (counts for 20% of the total score). No warning letter against SnagRx and no open flag, but one of its pharmacies, Triad Rx, had an FDA warning letter in 2019 that the FDA has closed out.
• Terms, commitment and refunds: 8/10 (counts for 10% of the total score). Monthly plans cancel anytime, the 12-month plans do not.
• Availability and fulfilment: 9.88/10 (counts for 5% of the total score). 48 states and free shipping.

We rescored SnagRx on October 10. Since our last check, price transparency rose from 9 to 10 and clinical care from 7.6 to 8.6. Terms fell from 10 to 8 after the refund page changed. Cost and value fell from 10 to 9, because two programs now charge less a month and its rank slipped to 3. The total holds at 9.3. On October 16 its group grew to 20 programs; its rank held at 3. On October 22 we matched its pharmacies against FDA compounding actions: Triad Rx's closed-out 2019 warning letter moved safety from 10 to 9.25, and its rank is now 4 of 21. The total is 9.1. The method is on our methodology page.